Managing cholesterol is a top public health priority in the Western world and the need for better products to assist will continue as emphasis on point-of-care tests grows. The prescription of statins is becoming an increasingly polarised debate. It appears highly likely that the pro-camp will continue to win, and that statins will be ever more widely prescribed.
Whilst home-test cholesterol kits appeared over 20 years ago, there is an established market led by a small and increasingly consolidated handful of companies providing products. RA Partners undertook a study to evaluate the opportunities for a new device in the field offering non-invasive diagnostic measurement.